Welcome to another edition of The Weekender.
We didn’t get to say it last week, so congratulations to the NPS Pharma team and their President and CEO Dr. Francois Nader, who received FDA approval for Natpara! This is NPS’s second drug approval in as many years and excellent news for the New Jersey life sciences ecosystem and a major accomplishment for the company.
BioNJ would also like to extend its congratulations to some of our Members and colleagues who along with our President and CEO Debbie Hart, were named to the NJBIZ‘s Power 100 list. They include Brent Saunders of Actavis, Bob Hugin and Rich Bagger of Celgene, Michele Brown of Choose NJ, Alex Gorsky of Johnson & Johnson, Ken Frazier of Merck, Tim Lizura of the NJEDA, Dr. Joel Bloom of NJIT, Dr. Robert Barchi of Rutgers, University and Dr. Nariman Farvardin of Stevens Institute of Technology.
As BioNJ buckles down, making final preparations for the Annual Dinner Meeting and Innovation Celebration, enjoy this week’s edition of The Weekender, featuring many different learning opportunities: The National Institutes of Health SBIR/STTR Grant Programs: Opportunity for Business Webinar; the 1st Pitch Life Science “Eavesdropping on Investor’s Closed Door Discussions”; Posters, Pitches and Prizes at Princeton – Hosted By The New Jersey Entrepreneurial Network and BIO Asia Business Development & Policy Delegation to Japan.
The Weekender will be on hiatus next week. See you at the Annual Dinner Meeting! Getting excited? Start the Twitter conversation by tweeting @BioNJ_org and use the hashtag #BioNJ.
Click here to read this week’s Weekender.